
Cullinan Therapeutics, Inc.
CGEMNASDAQHealthcare● Active
$13.11
$-0.40(-2.97%)
Market Cap$805609901
P/E Ratio—
52W High$16.74
52W Low$5.68
Cullinan Therapeutics, Inc.(CGEM)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · CGEM · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.02B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | ($0.00B) | $0.00B | $0.00B | $0.02B |
| Gross Margin %(computed) | — | — | — | — | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.19B | $0.14B | $0.15B | $0.09B | $0.06B |
| G&A Expenses | $0.05B | $0.05B | $0.04B | $0.04B | $0.03B |
| Total Operating Expenses | $0.24B | $0.20B | $0.19B | ($0.14B) | $0.09B |
| Operating Income | ($0.24B) | ($0.20B) | ($0.19B) | $0.14B | ($0.07B) |
| Operating Margin %(computed) | — | — | — | — | -358.73% |
| Interest Income | $0.02B | $0.03B | $0.02B | $0.01B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.22B) | ($0.17B) | ($0.17B) | $0.15B | ($0.07B) |
| Income Tax Expense | $0.00B | $0.00B | ($0.01B) | $0.04B | $0.00B |
| Net Income | ($0.22B) | ($0.17B) | ($0.15B) | $0.11B | ($0.07B) |
| Net Margin %(computed) | — | — | — | — | -346.14% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.72 | $-3.11 | $-3.69 | $2.46 | $-1.48 |
| Wtd Avg Shares | 0.06B | 0.05B | 0.04B | 0.05B | 0.04B |
| EBITDA | ($0.24B) | ($0.17B) | ($0.19B) | ($0.13B) | ($0.07B) |
| EBITDA Margin %(computed) | — | — | — | — | -358.45% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B
深入了解Cullinan Therapeutics, Inc.
关于Cullinan Therapeutics, Inc.(CGEM)损益表
Cullinan Therapeutics, Inc.(CGEM)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,CGEM实现营收$0.00B,毛利润$0.00B(毛利率—),净利润($0.22B)(净利率—)。
常见问题
CGEM · 4 问Cullinan Therapeutics, Inc.(CGEM)2025财年营收为$0.00B,同比down—%。
CGEM revenueCGEM salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08